NEPG: Subsidiary obtains drug registration certificate for L-carnitine oral solution

NEPG announced that its wholly-owned subsidiary, Shenyang Shide Pharmaceutical Co., Ltd., has received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration. The drug name is L-Carnitine Oral Solution, with the approval number Guo Yao Zhun Zi H20253799, valid until March 31, 2030. L-Carnitine Oral Solution is used for the treatment of primary systemic carnitine deficiency and also for the short-term and long-term treatment of secondary carnitine deficiency caused by congenital metabolic disorders. The acquisition of the L-Carnitine Oral Solution "Drug Registration Certificate" is beneficial for further enriching the company's product pipeline, enhancing the company's market competitiveness, and bringing new market opportunities